ABBV's slowdown in aesthetic procedures is mainly for dermal fillers and CoolSculpting, according to CEO Rick Gonzalez on today's CC. Dermal fillers and CoolSculpting are more expensive treatments than Botox.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”